FIELD: medicine. SUBSTANCE: method involves determining carcinogenic ingredients concentration in biological fluids of a patient like dimethyl nitrosoamine and diethyl nitrosoamine during the patient life. Database describing the ingredients availability in patient organism under study is formed. Carcinogenic ingredients concentration being high with respect to the previous treatment, malignant neoplasm availability is considered to be available. EFFECT: enhanced effectiveness of prognosis in early stage of disease development. 2 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD MEASURING QUANTITY OF NITROSO COMPOUNDS IN ENVIRONMENT | 1999 |
|
RU2159423C1 |
| DEVICE FOR METERING AMOUNT OF TOXIC SUBSTANCES IN ENVIRONMENT | 1999 |
|
RU2150692C1 |
| METHOD OF PREPARING R-TETRAOL ELICITING ANTITUMOR ACTIVITY | 2000 |
|
RU2196581C2 |
| METHOD OF MALIGNANT TUMOR DIAGNOSIS | 1993 |
|
RU2082981C1 |
| DIAGNOSTIC TECHNIQUE IN MALIGNANT SOLID TUMOURS AND REMOTE METASTASES | 2011 |
|
RU2456602C1 |
| METHOD OF PREVENTION OF CARCINOGENIC ACTION OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2358747C1 |
| METHOD FOR QUANTITATIVE DETERMINATION OF N-NITROSAMINES: N-DIMETHYLNITROSAMINE, N-METHYLETHYLNITROSAMINE, N-DIETHYLNITROSAMINE, N-DIBUTYLNITROSAMINE, N-DIPROPYLNITROSOAMINE, N-PIPERIDINE NITROSAMINE, N-PYRROLIDINE NITROSAMINE, N-MORPHOLIN NITROSAMINE, N-DIPHENYL NITROSAMINE, IN SAMPLES OF SMOKED MEAT PRODUCTS USING A METHOD OF CHROMATOGRAPHY-MASS SPECTROMETRY | 2017 |
|
RU2657822C1 |
| METHOD FOR RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN HPV 16-POSITIVE CERVICAL CANCER PATIENTS | 2018 |
|
RU2694834C1 |
| METHOD FOR PREDICTION OF CHEMOTHERAPEUTIC EFFECTIVENESS IN PATIENTS WITH MALIGNANT NEW GROWTHS OF EPITHELIAL TISSUES | 2013 |
|
RU2542505C1 |
| METHOD FOR PREDICTING EFFICACY OF CYTOSTATIC CHEMOTHERAPY IN PATIENTS SUFFERING MALIGNANT NEW GROWTHS OF EPITHELIAL TISSUES | 2014 |
|
RU2546533C9 |
